BE880777A - Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins - Google Patents

Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins

Info

Publication number
BE880777A
BE880777A BE0/198685A BE198685A BE880777A BE 880777 A BE880777 A BE 880777A BE 0/198685 A BE0/198685 A BE 0/198685A BE 198685 A BE198685 A BE 198685A BE 880777 A BE880777 A BE 880777A
Authority
BE
Belgium
Prior art keywords
reoviruses
vaccines
preparation
diseases caused
diseases
Prior art date
Application number
BE0/198685A
Other languages
English (en)
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of BE880777A publication Critical patent/BE880777A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE0/198685A 1978-12-20 1979-12-20 Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins BE880777A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7812359A NL7812359A (nl) 1978-12-20 1978-12-20 Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.

Publications (1)

Publication Number Publication Date
BE880777A true BE880777A (fr) 1980-06-20

Family

ID=19832096

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/198685A BE880777A (fr) 1978-12-20 1979-12-20 Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins

Country Status (5)

Country Link
US (1) US4515777A (fr)
JP (1) JPS5589232A (fr)
BE (1) BE880777A (fr)
NL (1) NL7812359A (fr)
ZA (1) ZA796944B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
US6136307A (en) * 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
RU2169581C1 (ru) * 1999-11-23 2001-06-27 Виноходов Владимир Олегович Вакцинный препарат и способ вакцинации птиц
AU2007215328A1 (en) * 2006-02-13 2007-08-23 Oncolytics Biotech Inc. Use of local immune suppression to enhance oncolytic viral therapy

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292949A (fr) *
US3083142A (en) * 1958-02-27 1963-03-26 Glaxo Group Ltd Improved swine erysipelas vaccine
US3060094A (en) * 1959-04-07 1962-10-23 Ray M Dutcher Preparation of virus vaccines
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
NL7012832A (fr) * 1970-08-29 1972-03-02
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
JPS529727B2 (fr) * 1971-12-29 1977-03-18
JPS506714A (fr) * 1973-05-31 1975-01-23
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
JPS529727A (en) * 1975-07-11 1977-01-25 Toyota Motor Corp Carburettor
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations
NL169413C (nl) * 1978-09-14 1982-07-16 Gist Brocades Nv Geinactiveerd vaccin, omvattende een waterige fase met een adeno-achtig virus (alv) en een oliefase, alsmede werkwijze voor het bereiden van een alv-vloeistof en virusstam, geschikt voor gebruik in een dergelijk vaccin.
DE2966914D1 (en) * 1978-09-14 1984-05-24 Gist Brocades Nv Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains

Also Published As

Publication number Publication date
NL7812359A (nl) 1980-06-24
JPS5589232A (en) 1980-07-05
US4515777A (en) 1985-05-07
ZA796944B (en) 1980-11-26

Similar Documents

Publication Publication Date Title
BE878430A (fr) Vaccins contre la pasteurellose
BE881097A (fr) Procede perfectionne de sterilisation
BE858992A (fr) Procede de preparation de vaccins
FR2328718A1 (fr) Procede microbiologique de preparation de 9a-hydroxyandrostene-dione
BE880844A (fr) Nouveaux derives de peptidyl-arginine-aldehydes et procede de preparation de ceux-ci
FR2388913B1 (fr) Materiau de rembourrage et procede de preparation dudit materiau
FR2320291A1 (fr) Procede de preparation de canthaxanthine
BE878916A (fr) Nouveaux derives du 3-aminoethyl phenol et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
RO79525A (fr) Procede de preparation d'un vaccin contre l'influenza
BE869498A (fr) Procede de sechage pour congelation pour la preparation de vaccin contre le meningocoque
PT68275A (fr) Procede pour la preparation de vaccins contre les maladiesprovoquees par des paramixovirus
RO77170A (fr) Procede de preparation des derives de 3(2-hydroxy)-4-subtitu-phenyle-cycloalkenones,cycloalkenoles,cycloalkanones et cycloalkanoles
BE875106A (fr) Medicaments anticomplementaires en partie antinephretiques, de type soya-sapogenol b et leur procede de preparation
FR2423849B1 (fr) Procede de prepara
RO79956A (fr) Procede de preparation des 3-halocephalosporines
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
DE2962169D1 (en) Chromanon derivatives, process for their preparation, and their use as medicines and growth-promoting agents
RO78342A (fr) Procede de preparation des imino-ethers de benzthiazolines et benzoxazolines
BE882270A (fr) Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique
BE877884A (fr) Procede de preparation de derives de cepheme
PT69288A (fr) Procede de preparation de derives benzylideniques
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
FR2320740A1 (fr) Derives du thiaxanthene, utilisables comme medicaments neuroleptiques et leur procede de preparation
BE831786A (fr) Vaccin contre la gravidite et procede de sa preparation
BE871586A (fr) Vaccin contre haemophilus influenzae et procede pour sa preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GIST-BROCADES N.V.

Effective date: 19911231